---
title: "TruAlt Bioenergy Ltd (TRUALT) — Share Price, Financials & Analysis"
symbol: "TRUALT"
company: "TruAlt Bioenergy Ltd"
canonical: "https://tapetide.com/stocks/TRUALT"
isin: "INE0MWH01014"
nse_symbol: "TRUALT"
bse_code: "544545"
sector: "Fast Moving Consumer Goods"
industry: "Agricultural Food & other Products"
market_cap_cr: 3577.17
generated_at: "2026-09-13T19:15:48.502Z"
---

# TruAlt Bioenergy Ltd (TRUALT)

Canonical page: https://tapetide.com/stocks/TRUALT

## Company

- **NSE Symbol:** TRUALT
- **BSE Code:** 544545
- **ISIN:** INE0MWH01014
- **Sector:** Fast Moving Consumer Goods
- **Industry:** Agricultural Food & other Products
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2025-10-03
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** trualtbioenergy.com

## About

Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector.[1]

## Latest Price

- **Price:** ₹416.35
- **Change:** -3.3 (-0.79%)
- **Open:** ₹416.1
- **Day High:** ₹423.95
- **Day Low:** ₹413.55
- **Previous Close:** ₹419.65
- **Volume:** 99815
- **As Of:** 2026-09-11T10:24:46+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:33.962738Z.

- **Market Cap:** ₹3577.17 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.5
- **P/E (TTM):** 22.84
- **EPS (TTM):** ₹18.23
- **Book Value:** ₹177.29
- **Price to Book:** 2.36
- **Dividend Yield:** 0%
- **ROE:** 6.14%
- **ROCE:** 10.77%
- **Debt to Equity:** 1.09
- **Revenue (yearly):** ₹1814 Cr
- **Net Income:** ₹96.9 Cr
- **EBITDA:** ₹376.2 Cr
- **52-Week High:** ₹549
- **52-Week Low:** ₹310.2
- **RSI (14):** 36.36

## Tapetide Score

- **Score:** 32 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 3.3 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 23.35 | 9% |
| growth | 33.75 | 9% |
| momentum | 48.8 | 12% |
| ownership | 28.48 | 24% |
| quality | 44.68 | 22% |
| valuation | 31.83 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoters have pledged 36.8% of their holding.
- Working capital days have increased from -31.2 days to 63.4 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y |
| --- | --- | --- | --- |
| cash flow growth | — | -186.43% | -933.23% |
| ebitda margin growth | -8.34% | 10.38% | 8.42% |
| net income growth | -13.81% | -33.9% | 39% |
| revenue growth | 2.31% | -7.85% | 31% |
| roce | -11.09% | -29.56% | -22.18% |
| roe | -13.9% | -67.8% | 12.41% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 197 | 388 | 415 | 907 | 304 | 115 | 713 | 596 | 627 |
| Expenses | 184 | 371 | 291 | 753 | 262 | 119 | 579 | 466 | 494 |
| Operating Profit | 14 | 17 | 125 | 154 | 42 | -5 | 134 | 129 | 133 |
| OPM % | 7 | 4.5 | 30 | 17 | 14 | -4 | 19 | 22 | 21 |
| Other Income | 15 | 17 | 15 | 14 | 23 | 15 | 18 | 31 | 15 |
| Interest | 35 | 34 | 36 | 39 | 38 | 39 | 40 | 44 | 44 |
| Depreciation | 16 | 16 | 18 | 18 | 21 | 21 | 22 | 23 | 25 |
| Profit before tax | -22 | -16 | 86 | 111 | 6 | -49 | 90 | 94 | 78 |
| Tax % | 0 | 15 | 13 | -1 | 18 | -23 | 23 | 27 | 24 |
| Net Profit | -22 | -19 | 75 | 112 | 5 | -38 | 69 | 69 | 59 |
| EPS in Rs | -3.05 | -2.64 | 10.65 | 15.81 | 0.67 | -4.42 | 8.08 | 7.91 | 6.66 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- |
| Sales | 762 | 1223 | 1908 | 1728 | 2050 |
| Expenses | 657 | 1035 | 1599 | 1438 | 1659 |
| Operating Profit | 105 | 188 | 309 | 290 | 392 |
| OPM % | 14 | 15 | 16 | 17 | 19 |
| Other Income | 0 | 57 | 61 | 86 | 78 |
| Interest | 35 | 143 | 144 | 160 | 166 |
| Depreciation | 21 | 57 | 67 | 86 | 90 |
| Profit before tax | 49 | 45 | 159 | 130 | 213 |
| Tax % | 28 | 29 | 8 | 25 | — |
| Net Profit | 35 | 32 | 147 | 97 | 159 |
| EPS in Rs | 5.81 | 5.21 | 20.76 | 11.19 | 18.23 |
| Dividend Payout % | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 61 | 61 | 71 | 86 |
| Reserves | 179 | 204 | 698 | 1435 |
| Borrowings | 1150 | 1685 | 1557 | 1652 |
| Other Liabilities | 465 | 469 | 704 | 606 |
| Total Liabilities | 1856 | 2418 | 3030 | 3778 |
| Fixed Assets | 1302 | 1427 | 1826 | 2185 |
| CWIP | 10 | 201 | 3 | 68 |
| Investments | 0 | 10 | 4 | 4 |
| Other Assets | 545 | 780 | 1197 | 1521 |
| Total Assets | 1856 | 2418 | 3030 | 3778 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 233 | 35 | 342 | -296 |
| Cash from Investing Activity | -1149 | -384 | -255 | -413 |
| Cash from Financing Activity | 920 | 367 | 40 | 648 |
| Net Cash Flow | 5 | 19 | 126 | -62 |
| Free Cash Flow | -42 | -321 | 82 | -806 |
| CFO/OP | 222 | 21 | 110 | -99 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 41 | 89 | 65 | 86 |
| Inventory Days | 112 | 72 | 60 | 173 |
| Days Payable | 225 | 70 | 139 | 89 |
| Cash Conversion Cycle | -72 | 92 | -14 | 170 |
| Working Capital Days | 8 | -130 | -27 | 63 |
| ROCE % | — | 11 | 14 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Promoters | 70.55% | 70.55% | 70.55% | 70.55% |
| FIIs | 1.3% | 0.93% | 0.66% | 0.58% |
| DIIs | 7.8% | 7.27% | 9.4% | 8.36% |
| Government | 0% | 0% | 0% | 0% |
| Public | 15.71% | 14.43% | 13.5% | 11.6% |
| Others | 4.64% | 6.82% | 5.88% | 8.91% |
| No. of Shareholders | 21 | 80013 | 73790 | 62478 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 423.52 | Sell |
| EMA (10) | 424.67 | Sell |
| SMA (20) | 437.86 | Sell |
| EMA (20) | 433 | Sell |
| SMA (50) | 441.24 | Sell |
| EMA (50) | 443.73 | Sell |
| SMA (100) | 462.17 | Sell |
| EMA (100) | 447.1 | Sell |
| SMA (200) | 432.08 | Sell |
| EMA (200) | 438.42 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 34.69 | Neutral |
| MACD (12,26,9) | -9.58 | Sell |
| Stochastic (14,3,3) | 17.33 | Buy |
| ADX (14) | 27.92 | Buy |
| Williams %R (14) | -86.86 | Buy |
| ATR (14) | 14.25 | High Volatility |
| ROC (12) | -5.85 | Sell |
| Stoch RSI (14) | 20.6 | Neutral |
| UO (7,14,28) | 39.47 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe9ab1b-bfec-4527-a11b-57d8c43ae475.pdf) |
| 2026-08-31 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72bbee7a-6d80-4282-bde3-d557c3394b74.pdf) |
| 2026-08-26 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e98e197e-d139-4235-8f4c-dfd6749050f0.pdf) |
| 2026-08-21 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c043b2c0-a6af-4567-99b3-1d1e1d9b817a.pdf) |
| 2026-08-13 | [Structural Digital Database](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0211eae7-ee94-43db-ab29-2f048d6ff6b2.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09514fb4-0b7a-4b66-a1ea-b1c1fc2bced7.pdf) |
| 2026-08-12 | [Structural Digital Database](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c5f89cb-d16d-4194-864f-db43deb031ea.pdf) |
| 2026-08-10 | [Structural Digital Database](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f17541c-d821-4fc1-97d9-01d0587553e6.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=797bb2dd-1da3-45e4-a433-a8b5ea4c974b.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7fecade-49f5-4bb7-a26a-efe77dcf1c21.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3adcdbf2-69a2-42e0-a804-ec1242d3729b.pdf) |
| 2026-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d43eb00-7a5f-4ab2-937a-c9f9721a6ccf.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d95c3a8-dfd0-4874-9792-f69beb278982.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2464a867-08cc-4a4a-8267-001ced7bce0f.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdf4c7fb-9374-4faa-acf2-73163e694583.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfb8033b-393b-44aa-b587-6f401c5f8136.pdf) |
| 2025-10-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3466d205-de23-4b1d-9430-f60634876ed9.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-22 | [Financial Results For The Quarter And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5247716-e67c-4a23-aa42-626d5c3c9e0b.pdf) |
| 2026-02-03 | [Consolidated And Standalone Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ed30bcf-6620-4b8d-b17e-b2497a804aa6.pdf) |
| 2025-11-11 | [Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7737e46b-2b04-4409-a747-e986df650574.pdf) |
| 2025-10-19 | [Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a7d7415-b566-4407-8686-7c407bb2bf4b.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00273a4a-f863-493b-8293-2350a4b28925.pdf) |
| 2026-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e149c802-673e-46f2-bbb2-7cb458c5df12.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1527b507-cbcf-4830-88a2-43fb06feb4fa.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3466d205-de23-4b1d-9430-f60634876ed9.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d33e3f11-88b5-4940-ba0b-31ffb1b1ac9e.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7d43eb00-7a5f-4ab2-937a-c9f9721a6ccf.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7d43eb00-7a5f-4ab2-937a-c9f9721a6ccf.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2464a867-08cc-4a4a-8267-001ced7bce0f.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2464a867-08cc-4a4a-8267-001ced7bce0f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Audio recording of earnings call for quarter and nine months ended Dec 31, 2025 available online. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9 Feb - Audio recording of earnings call for quarter and nine months ended Dec 31, 2025 available online.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e149c802-673e-46f2-bbb2-7cb458c5df12.pdf) |
| 6 Feb - High Court (04.02.2026) allowed writ; may supply 1,56,292 KL ethanol (~₹1,075 crore). | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 6 Feb - High Court (04.02.2026) allowed writ; may supply 1,56,292 KL ethanol (~₹1,075 crore).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fb6a6ed0-7028-4649-9c3c-09f7680e956c.pdf) |
| 4 Feb - Q3 FY26: ₹730.86cr income; Unit 5 commissioned; 100 MLpa SAF project; ₹150cr VGF potential | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 4 Feb - Q3 FY26: ₹730.86cr income; Unit 5 commissioned; 100 MLpa SAF project; ₹150cr VGF potential](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e2321b0-b598-4e63-a3aa-32d51a4a607d.pdf) |
| 30 Mar - Board designated CS Monu Kumar as authorized person; updated KMP list (March 30, 2026). | [Disclosure Under Regulation 30(5) Of SEBI (LODR) Regulation, 2015 30 Mar - Board designated CS Monu Kumar as authorized person; updated KMP list (March 30, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b112b5a7-e0ce-4c2f-a4be-1bd919c5328c.pdf) |
| 28 Apr - India Ratings assigned TruAlt Bioenergy bank facilities INR17,660 million at IND A-/Stable and IND A2+. | [Announcement under Regulation 30 (LODR)-Credit Rating 28 Apr - India Ratings assigned TruAlt Bioenergy bank facilities INR17,660 million at IND A-/Stable and IND A2+.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d45123bf-acc7-4fae-a013-0416f795d2d5.pdf) |
| 28 Apr - India Ratings assigned TruAlt Bioenergy bank facilities INR17,660 million at IND A-/Stable and IND A2+. | [Announcement under Regulation 30 (LODR)-Credit Rating 28 Apr - India Ratings assigned TruAlt Bioenergy bank facilities INR17,660 million at IND A-/Stable and IND A2+.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d45123bf-acc7-4fae-a013-0416f795d2d5.pdf) |
| 19 Mar - GAIL invests ₹130 million for 49% stake in Leafiniti, funding six CBG plants. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 19 Mar - GAIL invests ₹130 million for 49% stake in Leafiniti, funding six CBG plants.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a40a58dc-d74f-4d99-ad10-e84f2d61bbe1.pdf) |
| 13 Feb - Transcript: Q3/9M results; INR1,187 crore 9M revenue; SAF capex ~INR2,000–2,250cr; 24 CBG plants planned; GAIL equity infusion. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 13 Feb - Transcript: Q3/9M results; INR1,187 crore 9M revenue; SAF capex ~INR2,000–2,250cr; 24 CBG plants planned; GAIL equity infusion.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98ac9945-55de-42d2-95d3-b567cd359c4e.pdf) |
| 10 Feb - Crisil MA reports Rs750 crore IPO proceeds; Rs519.63 crore used, Rs230.37 crore unutilized as of Dec 31, 2025. | [Monitoring Agency Report 10 Feb - Crisil MA reports Rs750 crore IPO proceeds; Rs519.63 crore used, Rs230.37 crore unutilized as of Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6b6f62f-d4d2-4ba0-add9-dc5c3eed9dbe.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/804f9a94-7e2c-4945-838c-b3a263a8f2f0.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e06c23c5-f94a-43b8-a6f2-b140f233824d.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:15:48.502Z.